Riyad Seervai
Portland, ORNPI 1235872615
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,569 of the $9,929 with a category attached, or 86.3%. It is spread thinly across 19 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $5,840, more than ten times the $549 reported in 2023.
Across 97 payments — averaging $102.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novartis$1K
- Sanofi$1K
- Janssen Scientific Affairs, LLC$942
- Galderma Laboratories, L.p.$797
- Arcutis Biotherapeutics, Inc.$597
- plus $3K from 13 others
What the payments were for
- Speaking & faculty fees$2192%
- Travel & lodging$1,14212%
- Food & beverage$8,56986%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $1,956 |
| Novartis | 13 | $1,395 |
| Sanofi | 10 | $1,021 |
| Janssen Scientific Affairs, LLC | 9 | $942 |
| Galderma Laboratories, L.p. | 7 | $797 |
| Arcutis Biotherapeutics, Inc. | 8 | $597 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $561 |
| Johnson & Johnson | 4 | $548 |
| UCB, Inc. | 5 | $415 |
| Amgen | 5 | $347 |
| Dermavant Sciences, Inc. | 3 | $313 |
| Incyte Corporation | 5 | $306 |
| Sun Pharmaceutical Industries Inc. | 4 | $305 |
| Lilly USA, LLC | 1 | $118 |
| Boehringer Ingelheim | 1 | $98 |
| Boehringer Ingelheim International GmbH | 1 | $82 |
| Pfizer | 1 | $62 |
| Almirall LLC | 1 | $46 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 48 | $1,708 |
| Tacrolimus | 14 | $1,082 |
| Triamcinolone Acetonide | 25 | $336 |
| Doxycycline Monohydrate | 11 | $294 |
| Ketoconazole | 15 | $270 |
| Dexamethasone | 11 | $207 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.